Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -31.43%-51.96M | ---- | 18.06%-39.54M | ---- | -10.00%-48.25M | ---- | 70.01%-43.86M | ---- | -15.14%-146.24M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1K | ---- | ---- |
| Impairment and provisions: | ---- | 162.30%34.77M | ---- | -48.53%13.26M | ---- | 19.10%25.75M | ---- | -40.44%21.62M | ---- | -56.97%36.3M |
| -Impairmen of inventory (reversal) | ---- | 429.91%16.35M | ---- | -79.80%3.09M | ---- | -50.95%15.28M | ---- | -14.19%31.15M | ---- | -35.63%36.3M |
| -Impairment of trade receivables (reversal) | ---- | 81.09%18.42M | ---- | -2.89%10.17M | ---- | --10.47M | ---- | ---- | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.1M | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---12.63M | ---- | ---- |
| Revaluation surplus: | ---- | -91.68%456K | ---- | 22,933.33%5.48M | ---- | 99.46%-24K | ---- | -235.84%-4.43M | ---- | -4.15%3.26M |
| -Other fair value changes | ---- | -91.68%456K | ---- | 22,933.33%5.48M | ---- | 99.46%-24K | ---- | -235.84%-4.43M | ---- | -4.15%3.26M |
| Asset sale loss (gain): | ---- | ---- | ---- | ---43K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---43K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -20.86%8.95M | ---- | 5.05%11.31M | ---- | 22.11%10.76M | ---- | 83.49%8.82M | ---- | 8.74%4.8M |
| Financial expense | ---- | 0.59%2.38M | ---- | 22.34%2.37M | ---- | 7.86%1.93M | ---- | 61.82%1.79M | ---- | -33.17%1.11M |
| Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -92.44%4.65M | ---- | 869.60%61.43M |
| Operating profit before the change of operating capital | ---- | 24.53%-5.41M | ---- | 26.99%-7.17M | ---- | 13.93%-9.82M | ---- | 70.99%-11.41M | ---- | -46.50%-39.34M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 181.97%19.13M | ---- | -95.24%-23.34M | ---- | 35.15%-11.95M | ---- | -18.46%-18.43M | ---- | -243.77%-15.56M |
| Accounts receivable (increase)decrease | ---- | -140.74%-9.82M | ---- | 294.47%24.1M | ---- | -344.25%-12.39M | ---- | -89.20%5.07M | ---- | 322.49%46.98M |
| Accounts payable increase (decrease) | ---- | 67.38%-1.52M | ---- | -673.22%-4.67M | ---- | -78.41%814K | ---- | 149.36%3.77M | ---- | -6,781.08%-7.64M |
| prepayments (increase)decrease | ---- | -94.24%807K | ---- | -67.26%14.02M | ---- | 113.38%42.81M | ---- | --20.06M | ---- | ---- |
| Financial assets at fair value (increase)decrease | ---- | ---- | ---- | 33.28%-2.73M | ---- | -201.62%-4.1M | ---- | 22.71%-1.36M | ---- | ---1.76M |
| Cash from business operations | ---- | 1,417.14%3.19M | ---- | -96.08%210K | ---- | 333.51%5.36M | ---- | 86.74%-2.3M | ---- | -244.90%-17.31M |
| Special items of business | -1,101.70%-2.82M | ---- | 97.18%-235K | ---- | -4,041.79%-8.33M | ---- | 88.67%-201K | ---- | -208.17%-1.77M | ---- |
| Net cash from operations | -1,101.70%-2.82M | 1,417.14%3.19M | 97.18%-235K | -96.08%210K | -4,041.79%-8.33M | 333.51%5.36M | 88.67%-201K | 86.74%-2.3M | -208.17%-1.77M | -249.28%-17.31M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1K | ---- | ---- |
| Purchase of fixed assets | ---- | ---- | ---- | ---- | ---- | 86.55%-960K | ---- | ---7.14M | ---- | ---- |
| Sale of subsidiaries | ---- | ---- | ---- | ---2.57M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.54M | ---- | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | -122.22%-4.9M | ---- | ---2.21M | ---- |
| Net cash from investment operations | ---- | ---- | ---- | -167.29%-2.57M | ---- | 88.94%-960K | -122.22%-4.9M | ---8.68M | ---2.21M | ---- |
| Net cash before financing | -1,101.70%-2.82M | 235.23%3.19M | 97.18%-235K | -153.56%-2.36M | -63.20%-8.33M | 140.09%4.4M | -28.20%-5.1M | 36.62%-10.97M | -342.62%-3.98M | -236.39%-17.31M |
| Cash flow from financing activities | ||||||||||
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 74.89%10.4M | ---- | --5.95M |
| Issuance of bonds | ---- | ---- | ---- | ---- | ---- | -51.57%4.41M | ---- | -40.06%9.12M | ---- | --15.21M |
| Interest paid - financing | ---- | 53.15%-647K | ---- | 14.59%-1.38M | ---- | -27.52%-1.62M | ---- | ---1.27M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | -2,701.09%-5.15M | ---- | -23.49%-184K | ---- | ---149K |
| Other items of the financing business | 1,132.44%4.23M | ---- | ---410K | ---- | ---- | ---- | ---- | ---- | --4.2M | ---- |
| Net cash from financing operations | 1,132.44%4.23M | 22.03%-4.22M | ---410K | 6.32%-5.41M | ---- | -136.08%-5.77M | ---- | -23.83%16M | --4.2M | 374.26%21M |
| Effect of rate | -303.57%-57K | -69.31%62K | -39.13%28K | -74.69%202K | -76.41%46K | 445.45%798K | 125.42%195K | -14.93%-231K | -130.74%-767K | -102.46%-201K |
| Net Cash | 318.45%1.41M | 86.73%-1.03M | 92.25%-645K | -465.40%-7.76M | -63.20%-8.33M | -127.32%-1.37M | -2,450.69%-5.1M | 36.24%5.03M | -86.77%217K | 128.81%3.69M |
| Begining period cash | -48.45%1.03M | -79.10%2M | -79.10%2M | -5.67%9.56M | -5.67%9.56M | 89.81%10.13M | 89.81%10.13M | 188.44%5.34M | 188.44%5.34M | -71.50%1.85M |
| Cash at the end | 72.48%2.38M | -48.45%1.03M | 7.89%1.38M | -79.10%2M | -75.52%1.28M | -5.67%9.56M | 9.17%5.23M | 89.81%10.13M | -20.00%4.79M | 188.44%5.34M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | China Credit Letter (Hong Kong) Certified Public Accountants Limited | -- | China Credit Letter (Hong Kong) Certified Public Accountants Limited | -- | Chang Ying (Hong Kong) Certified Public Accountants Limited | -- | Chang Ying (Hong Kong) Certified Public Accountants Limited | -- | Chang Ying (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.